PETACH TIKVA, Israel — November 13, 2025 — Leads & Copy — Nanox Imaging Ltd. (NASDAQ: NNOX) will showcase its Nanox.ARC X multi-source digital tomosynthesis system and highlight its AI portfolio at the Radiological Society of North America (RSNA) 2025 Annual Meeting in Chicago, Nov. 30 – Dec. 4.
The Nanox.ARC X, cleared by the FDA in April 2025, is designed to make 3D imaging more accessible and affordable, with lower radiation doses than CT scans. It has general use clearance for musculoskeletal, pulmonary, intra-abdominal, and paranasal indications. Attendees of RSNA 2025 will be able to see live demonstrations of the system at Booth #3914 every 30 minutes, where Nanox will also present clinical data supporting digital tomosynthesis across various applications.
Nanox will also announce a pulmonary nodule AI solution, currently in development for the Nanox.ARC X, along with two new standalone AI innovations for aortic valve calcification measurement and body composition measurements.
Erez Meltzer, CEO and Acting Chairman of Nanox, said the Nanox.ARC X bridges the gap between conventional X-rays and CT scans, bringing advanced 3D imaging to everyday care settings. He added that the company is delivering on its vision to leverage its AI and proprietary digital X-ray source technology to make advanced medical imaging accessible to more patients, in more places, and is excited to unveil the Nanox.ARC X system to the radiology community for the first time and highlight their expanding AI portfolio, featuring two new AI innovations in development.
Nanox’s RSNA 2025 presentations and events include:
- Innovation Theater Presentation: “Nanox: From Vision to Reality – AI and Digital Tomosynthesis in Pulmonary Nodule Detection” with Orit Wimpfheimer, MD, Chief Medical Officer of Nanox, on December 2 from 11:00-11:20 am CT at Innovation Theater, Booth 3316, South Hall A.
- Educational Exhibit Poster Presentation: “Applications of Digital Tomosynthesis in the Musculoskeletal System” with authors Nogah Shabshin, MD, Mor Armoni, Yotam Kimmel, Guy Yoskovitz, Yael S. Schiffenbauer, PhD, Ophir Robenpour, MD, Sigal Tal, MD, and Yiftah Beer, MD, starting November 30 at 7:30 am CT at the Learning Center, East Level 3.
- Cocktail Event: Hosted by Lawrence Tanenbaum, MD, Nanox Advisory Board Member, on December 1 at 5:30 pm CT at VU Rooftop Bar, 22nd floor of Hilton Garden Inn, McCormick Place. (Contact Nanox team to register)
Nanox representatives will be available throughout RSNA 2025 for product demonstrations, clinical discussions, and partnership opportunities at booth #3914, with Sharon Saban, General Manager, Nanox AI Division, also available at booth #3914.
Nanox (NASDAQ: NNOX) aims to drive the transition to preventive healthcare by providing affordable medical imaging technologies based on AI and digital X-ray source technology. The Nanox ecosystem includes Nanox.ARC, Nanox.AI LTD, Nanox.CLOUD, and Nanox.MARKETPLACE.
Media Contact:
Ben Shannon
ICR Healthcare
NanoxPR@icrinc.com
Investor Contact:
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Source: Nanox
